Ajanta Pharma Limited has entered into a share purchase agreement to acquire 100% equity share capital of MViyeS Pharma Ventures Private Limited (MViyeS).

 

The acquisition was completed on November 6, 2020. Before acquisition, MViyeS was holding 32.18% shareholding in Eugia Pharma Specialities Limited, a joint venture company in which the company is holding the balance 67.82%.

 

Now, both Eugia Pharma Specialities Limited and MViyeS Pharma Ventures Private Limited have become 100% subsidiaries of Ajanta Pharma Limited. 

 

Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages. Committed to 'Serve Health Care Needs Worldwide', the company produces a comprehensive range of specialty products targeting different therapeutic segments for treatment of patients, customised to each market. The company's business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and institution sales.